Bcl-2 and Androgen Receptor Gene Expression in Androgen-Independent Subclone Derived from Mouse Androgen-Dependent Cells

REFERENCES

• Oh W.K., Kantoff P.W. Management of Hormone Refractory Prostate Cancer: Current Standards and Future Prospects. J. Urol. 1998; 160: 1220–1229
   Google Scholar
• Evans B.A.J., Harper M.E., Daniells C.E., Watts C.E., Matenhelia S., Green J., Griffiths K. Low Incidence of Androgen Receptor Gene Mutations in Human Prostatic Tumors Using Single Strand Conformation Polymorphism Analysis. Prostate 1996; 28: 162–171
   PubMed Web of Science ®Google Scholar
• Furuya Y., Isaacs J.T., Shimazaki J. Induction of Programmed Death/Apoptosis in Androgen-Dependent Mouse Mammary Tumor Cell Line (Shionogi Carcinoma 115) by Androgen Withdrawal. Jpn. J. Cancer Res. 1995; 86: 1159–1165
   PubMedGoogle Scholar
• Ohigashi T., Ueno M., Iida M., Hirata R., Nakanoma T., Deguchi N. Suppression of Default Apoptosis in Androgen-Dependent Cells by Testosterone-Mediated bcl-2 Expression. Int. J. Urol. 1999; 6: 119–124
   PubMedGoogle Scholar
• Yamaguchi T., Kawamoto K., Uchida N., Uchida K., Watanabe S. Three Cell Lines Showing Androgen-Dependent, -Independent, and -Suppressed Phenotypes, Established from a Single Tumor of Androgen-Dependent Shionogi Carcinoma 115. In Vitro Cell Dev. Biol. 1992; 28A: 245–254
   PubMed Web of Science ®Google Scholar
• Carmichael J., Degraff W.G., Gazdar A.F., Minna J.D., Mitchell J.B. Evaluation of a Tetrazolium-Based Semi-automated Colorimetric Assay: Assessment of Chemosensitivity Testing. Cancer Res. 1984; 47: 936–942
   Google Scholar
• Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of Programmed Cell Death In Situ via Specific Labeling of Nuclear DNA Fragmentation. J. Cell Biol. 1992; 119: 493–501
   PubMed Web of Science ®Google Scholar
• Negrini M., Silini E., Kozak C.A., Tsujimoto Y., Croce C.M. Molecular Analysis of mbcl-2: Structures and Expression of the Murine Gene Homologous to the Human Gene Involved in Follicular Lymphoma. Cell 1987; 49: 455–463
   PubMed Web of Science ®Google Scholar
• Brandstrom A., Westin P., Bergh A., Cajander S., Damber J.-E. Castration Induces Apoptosis in the Ventral Prostate But Not in an Androgen-Sensitive Prostatic Adenocarcinoma in the Rat. Cancer Res. 1994; 54: 3594–3601
   PubMed Web of Science ®Google Scholar
• Hengartner M.O., Horvitz H.R. C. elegans Cell Survival Gene Ced-9 Encodes a Functional Homologue of the Mammalian Proto-Oncogene bcl-2. Cell 1994; 76: 665–676
   PubMed Web of Science ®Google Scholar
• Raffo A.J., Perlman H., Chen M., Day M.L., Streitman J.S., Buttyan R. Overexpression of bcl-2 Protects Prostate Cancer Cells from Apoptosis In Vitro and Confers Resistance to Androgen Depletion In Vivo. Cancer Res. 1995; 55: 4438–4445
   PubMed Web of Science ®Google Scholar
• Miyake H., Tolcher A., Gleave M.E. Antisense bcl-2 Oligodeoxynucleotides Inhibit Progression to Androgen-Independence After Castration in the Shionogi Tumor Model. Cancer Res. 1999; 59: 4030–4034
   PubMed Web of Science ®Google Scholar
• McDonnell T.J., Troncoso P., Brisbay S.M., Logothetis C., Chung L.W.K., Hsieh J.-T., Tu S.-M., Campbell M.L. Expression of the Protooncogene bcl-2 in the Prostate and Its Association with Emergence of Androgen-Independent Prostate Cancer. Cancer Res. 1992; 52: 6940–6944
   PubMed Web of Science ®Google Scholar
• Veldscolte J., Ris-Stalpers C., Kuiper G.G.J.M., Jenster G., Berrevoets C., Claassen E., van Rooij H.C.J., Trapman J., Brinkmann A.O., Mulder E. A Mutation in the Ligand Binding Domain of the Androgen Receptor of Human LNCaP Cells Affects Steroid Binding Characteristics and Response to Anti-androgens. Biochem. Biophys. Res. Commun. 1990; 173: 534–540
   PubMed Web of Science ®Google Scholar
• Smith C.B., Ghamadian R., Chilsholm G.D. Inhibition of the Nuclear Dihydrotestosterone Receptor Complex from Rat Ventral Prostate by Antiandrogens and Stilboesterol. Mol. Cell. Endocrinol. 1978; 10: 13–20
   PubMedGoogle Scholar
• Visakorpi T., Hyytinen E., Koivisto P., Tanner M., Kainanen R., Palmberg C., Paloue A., Tammela T., Isola J., Kallioniemi O.-P. In Vivo Amplification of the Androgen Receptor Gene and Progression of Human Prostate Cancer. Nat. Genet. 1995; 9: 401–406
   PubMed Web of Science ®Google Scholar
• Ohigashi T., Ueno M., Nonaka S., Nakanoma T., Furukawa Y., Deguchi N., Murai M. Tyrosine Kinase Inhibitors Reduce bcl-2 Expression and Induce Apoptosis in Androgen-Dependent Cells. Am. J. Physiol. (Cell Physiol.) 2000; 278: C66–C72
   PubMed Web of Science ®Google Scholar
• Miyamoto H., Yeh S., Wilding G., et al. Promotion of Agonist Activity of Antiandrogens by the Androgen Receptor Coactivator, ARA70, in Human Prostate Cancer DU145 Cells. Proc. Natl Acad. Sci. USA 1998; 95: 7379–7384
   PubMed Web of Science ®Google Scholar
• Webb A., Cunnigham D., Cotter F., Clarke P.A., di Stefano F., Ross P., Corbo M., Dziewanowska Z. BCL-2 Antisense Therapy in Patients with Non-Hodgkin Lymphoma. Lancet 1997; 349: 1137–1141
   PubMed Web of Science ®Google Scholar